1. |
Cao W, Chen HD, Yu YW, et al. Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020. Chin Med J (Engl), 2021, 134(1): 783-7918.Cao W, Chen HD, Yu YW, et al. Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020. Chin Med J (Engl), 2021, 134(1): 783-7918.
|
2. |
中国临床肿瘤学会指南工作委员会. 中国临床肿瘤学会 (CSCO) 分化型甲状腺癌诊疗指南 2021. 肿瘤预防与治疗, 2021, 34(12): 1164-1200.
|
3. |
Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 2021, 71(3): 209-249.
|
4. |
程若川, 刘文. 中国甲状腺癌术后随访和临床研究现状反思. 中国普通外科志, 2017, 26(11): 1375-1382.
|
5. |
蔡明, 胡紫宜, 张琨, 等. 甲状腺癌术后患者随访需求调查及影响因素分析. 中国普外基础与临床杂志, 2021, 28(9): 1193-1199.
|
6. |
Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines Task Force on thyroid nodules and differentiated thyroid cancer. Thyroid, 2016, 26(1): 1-133.
|
7. |
刘洁, 高静, 唐媛, 等. 中文版甲状腺癌特异性生命质量量表的信效度评价. 肿瘤, 2019, 39(3): 178-187.
|
8. |
Husson O, Haak HR, Mols F, et al. Development of a disease-specific health-related quality of life questionnaire (THYCA-QoL) for thyroid cancer survivors. Acta Oncol, 2013, 52(2): 447-454.
|
9. |
Chen C, Cao J, Wang Y, et al. Health-related quality of life and thyroid cancer-specific symptoms in patients treated for differentiated thyroid cancer: a single-center cross-sectional survey from Mainland China. Thyroid, 2023, 33(4): 474-483.
|
10. |
Chan WL, Choi HC, Lang B, et al. Health-related quality of life in asian differentiated thyroid cancer survivors. Cancer Control, 2021, 28: 10732748211029726. doi: 10.1177/10732748211029726.
|
11. |
Dionisi-Vici M, Fantoni M, Botto R, et al. Distress, anxiety, depression and unmet needs in thyroid cancer survivors: a longitudinal study. Endocrine, 2021, 74(3): 603-610.
|
12. |
Wang T, Jiang M, Ren Y, et al. Health-related quality of life of community thyroid cancer survivors in Hangzhou, China. Thyroid, 2018, 28(8): 1013-1023.
|
13. |
Rogers SN, Mepani V, Jackson S, et al. Health-related quality of life, fear of recurrence, and emotional distress in patients treated for thyroid cancer. Br J Oral Maxillofac Surg, 2017, 55(7): 666-673.
|
14. |
Husson O, Nieuwlaat WA, Oranje WA, et al. Fatigue among short- and long-term thyroid cancer survivors: results from the population-based PROFILES registry. Thyroid, 2013, 23(10): 1247-1255.
|
15. |
Goldfarb M, Casillas J. Thyroid cancer-specific quality of life and health-related quality of life in young adult thyroid cancer survivors. Thyroid, 2016, 26(7): 923-932.
|
16. |
Choi Y, Lee JH, Kim YH, et al. Impact of postthyroidectomy scar on the quality of life of thyroid cancer patients. Ann Dermatol, 2014, 26(6): 693-699.
|
17. |
Jung MS, Visovatti M. Post-treatment cognitive dysfunction in women treated with thyroidectomy for papillary thyroid carcinoma. Support Care Cancer, 2017, 25(3): 915-923.
|
18. |
Huang SM, Lee CH, Chien LY, et al. Postoperative quality of life among patients with thyroid cancer. J Adv Nurs, 2004, 47(5): 492-499.
|
19. |
Mols F, Schoormans D, Smit JWA, et al. Age-related differences in health-related quality of life among thyroid cancer survivors compared with a normative sample: Results from the PROFILES Registry. Head Neck, 2018, 40(10): 2235-2245.
|
20. |
田文, 张浩. 分化型甲状腺癌术后管理中国专家共识(2020版). 中国实用外科杂志, 2020, 40(09): 1021-1028.
|
21. |
Walshaw EG, Smith M, Kim D, et al. Systematic review of health-related quality of life following thyroid cancer. Tumori, 2022, 108(4): 291-314.
|
22. |
Vigário Pdos S, Chachamovitz DS, Teixeira Pde F, et al. Exercise is associated with better quality of life in patients on TSH-suppressive therapy with levothyroxine for differentiated thyroid carcinoma. Arq Bras Endocrinol Metabol, 2014, 58(3): 274-281.
|
23. |
Haraj NE, Bouri H, El Aziz S, et al. Evaluation of the quality of life in patients followed for differentiated cancer of the thyroid. Ann Endocrinol (Paris), 2019, 80(1): 26-31.
|
24. |
Almeida JP, Vartanian JG, Kowalski LP. Clinical predictors of quality of life in patients with initial differentiated thyroid cancers. Arch Otolaryngol Head Neck Surg, 2009, 135(4): 342-346.
|
25. |
Coerts HI, de Keizer B, Marlowe RJ, et al. Recombinant or endogenous thyroid-stimulating hormone for radioactive iodine therapy in thyroid cancer: state of knowledge and current controversies. Eur J Endocrinol, 2023, 188(2): lvad006. doi: 10.1093/ejendo/lvad006.
|